TAl/Tau Aggregation Inhibiting Peptide
Tau aggregation inhibitor for neurodegenerative disease research, potentially effective against Alzheimer's disease.
$120.00 / unit
1
Total:$120.00
GMP Compliant≥99% PurityGlobal Shipping
Tau protein aggregation inhibitory peptides inhibit the aggregation of Tau protein — a key factor in neurodegenerative diseases such as Alzheimer's.
Key Benefits
- Inhibits Tau protein aggregation
- May delay neurodegenerative disease progression
- Crosses the blood-brain barrier (oral activity in some variants)
- Improves behavioral phenotypes in disease models
Reconstitution Instructions
- Reconstitute per research protocol
- Store as directed
Dosing Guidelines
- Per research protocol guidelines
Product Note
Customization available. RI-AG03 is an example oral-activity Tau aggregation inhibitor.